Personal profile

Short presentation

Research Funding obtained from :

Dr. Ibler has obtained research funding from Leo Foundation (investigating contact dermatitis in the fishing industry in Greenland), Almirall (investigating micro- and mycobioma in Lebrikizumab treated patients), The Working Environment Research Fund (investigating contact dermattitis in cleaners and development of preventive pictograms) and Region Zealand Research Fund (investigating contact dermatitis in healthcare workers and development of a prevention programme).

 

Travel grants :

Travel grants for participation in Dermatology congresses or symposia have been provided by Sanofi, Leo Pharma and Almirall.

Possible conflicts of interest

Dr. Ibler has served as a speaker or participated in advisory boards for Sanofi, AbbVie, LEO Pharma, Pfizer, Eli Lilly and Almirall.

She has served as primary investigator or subinvestigator in clinical trials for Almirall, Leo Pharma and Abbvie and Sanofi. 

Dr. Ibler has received honoraria from Leo Pharma for writing patient information folders regarding atopic dermatitis and contact dermatitis.

 

As a clinical associate professor, I hold a dual appointment, meaning that I am employed both by the Capital Region of Denmark and the University of Copenhagen. For an overview of potential conflicts of interest, please refer to my research profile in the region.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or